Advancing theranostics with tumor-targeting peptides for precision otolaryngology
Worldwide, about 600,000 head and neck squamous cell carcinoma (HNSCC) are detected annually, many of which involve high risk human papilloma virus (HPV). Surgery is the primary and desired first treatment option. Following surgery, the existence of cancer cells at the surgical margin is strongly as...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
KeAi Communications Co., Ltd.
2016
|
| Subjects: | |
| Online Access: | https://doaj.org/article/33082bea6a85492fbfd2fa98ad88e7d8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|